J&J | JNJ - DEBITO





DEBITO Cambiamento Data
AbbVie USD 72.86B 5.36B 2026-03
Abbott USD 34.05B 20.19B 2026-03
Amgen USD 57.32B 2.72B 2026-03
AstraZeneca USD 32.24B 1.68B 2026-06
Baxter International USD 9.69B 93M 2026-03
Bayer EUR 36.45B 2.93B 2025-12
Becton, Dickinson and Co. USD 17.28B 2.26B 2026-03
Biogen USD 8.09B 1.53B 2026-06
Boston Scientific USD 11.03B 407M 2026-03
Bristol-Myers Squibb USD 46.43B 711M 2026-03
CONMED USD 860.87M 25.93M 2026-03
Cooper Companies USD 2.5B 5.6M 2025-12
Dexcom USD 1.24B 900K 2026-03
Edwards Lifesciences USD 600M 105.4M 2026-03
Eli Lilly USD 43.37B 867M 2026-03
Gilead Sciences USD 22.17B 2.76B 2026-03
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Globus Medical USD 115.22M 3.43M 2026-03
Insulet USD 948.4M 300K 2026-06
Integra LifeSciences USD 2.04B 6.27M 2026-03
Intuitive Surgical USD 0 0 2025-03
J&J USD 54.99B 7.05B 2026-03
Medtronic USD 28.07B 1.03B 2025-12
Merck USD 49.12B 222M 2026-03
Merit Medical Systems USD 821.56M 9K 2026-03
Novartis USD 49.01B 2.02B 2026-06
Pfizer USD 63.73B 231M 2026-03
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 23.58B 3.56B 2026-06
Stryker USD 14.19B 32M 2026-06
Tandem Diabetes Care USD 602.58M 132.16M 2026-06
Teva Pharmaceutical Industries USD 16.91B 187M 2026-03
Vertex Pharmaceuticals USD 1.99B 44M 2026-03
Zimmer Biomet Holdings USD 7.48B 8M 2026-06
Zoetis USD 9.24B 0 2026-03